Category Archives: Tms

As the legal battle between Elon Musk and Dogecoin investors heats up, many meme coin investors are beginning to worry about the potential negative impact on their investments in Dogecoin (DOGE) and Shiba Inu (SHIB). In search of more secure and reliable investment options, a growing number of investors are now turning to innovative platforms like TMS Network (TMSN), which has rapidly emerged as a leader in the crypto investment space.

Shiba Inu (SHIB)

Shiba Inu (SHIB) is a cryptocurrency that has gained immense popularity among meme coin investors, with the Shiba Inu (SHIB) project boasting a passionate community. The cryptocurrency is often referred to as the Dogecoin killer and aims to offer a decentralized ecosystem for SHIB holders.

Despite being a relatively new player in the crypto space, Shiba Inu (SHIB) has already gained a significant following, with its native token SHIB pivoting from its memecoin roots to also provide DeFi services and trading through ShibaSwap. The cryptocurrencys chart trends have been volatile, but many investors see potential in Shiba Inu (SHIB) and are keeping a close eye on its progress.

As Shiba Inu (SHIB) struggles to justify ongoing growth with limited utility, traders are increasingly looking at new investment options like TMS Network (TMSN), but Shiba Inu (SHIB) could still provide modest returns for investors.

Dogecoin (DOGE)

Dogecoin (DOGE) is a cryptocurrency that was created as a lighthearted alternative to Bitcoin in 2013, but despite its playful origin, Dogecoin (DOGE) has gained significant popularity over the years with its user base extending beyond the typical crypto enthusiasts to include mainstream investors and celebrities.

One of the key features of Dogecoin (DOGE) is its fast transaction processing time, which is achieved through its use of the Scrypt algorithm. This has made Dogecoin (DOGE) a popular choice for microtransactions and has contributed to its growing acceptance as an accessible means of alternative payment.

The unique culture and community surrounding Dogecoin (DOGE) sets it apart from other memecoins and highlights the potential for blockchain technology as a means of payment. As investors continue to look for big profits, Dogecoin (DOGE) looks as if it could still produce decent returns, despite its high popularity.

TMS Network (TMSN)

TMS Network (TMSN) is a trading platform that is transforming the way investors approach digital assets. With its commitment to convenience and scalability, TMS Network (TMSN) provides a comprehensive trading experience that is accessible to traders of all levels.

Its no surprise that TMS Network looks set to produce big returns for early investors given that TMS Network (TMSN) boasts such a user-friendly interface, which simplifies the trading process and encourages broader participation in the world of digital assets, while the platforms social trading feature allows users to follow and replicate the trades of successful investors, making it easier for novice traders to learn from experts.

TMS Network (TMSN) has also impressed investors with its dedication to trader education, and it provides a wealth of resources to help its users navigate the complexities of the crypto investment space. Its blockchain-based platform ensures safe, fast, and transparent trading, and its versatility allows traders to invest in cryptocurrencies, CFDs, Forex, and global stocks all in one seamless experience.

Conclusion

The challenges facing memecoin projects such as Dogecoin (DOGE) and Shiba Inu (SHIB) are clear, and so given that TMS Network (TMSN) has rapidly risen to a hundred times its previous price, investors are flocking to secure their TMSN tokens as quickly as possible. And who can blame them with such a bright future ahead of the project?

Click here for more information about TMS Network (TMSN):Presale: https://presale.tmsnetwork.ioWhitepaper: https://tmsnetwork.io/whitepaper.pdfWebsite: https://tmsnetwork.ioTelegram: https://t.me/tmsnetworkioDiscord: https://discord.gg/njA95e7au6

Disclaimer:The statements, views and opinions expressed in this article are solely those of the content provider and do not necessarily represent those of Crypto Reporter. Crypto Reporter is not responsible for the trustworthiness, quality, accuracy of any materials in this article. This article is provided for educational purposes only. Crypto Reporter is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article. Do your research and invest at your own risk.

Go here to read the rest:

Could Musk Suit Have Negative Impact on Dogecoin (DOGE) and ... - Crypto Reporter

Logistics technology has revolutionized the way businesses handle the transportation and delivery of goods.

It has made the process more efficient and effective, leading to increased customer satisfaction and profitability. In this article, we will discuss logistics technology and its impact on the industry.More info.

Logistics technology refers to the use of software, hardware, and other digital tools to streamline and optimize logistics operations. It includes transportation management systems (TMS), warehouse management systems (WMS), and supply chain management (SCM) software. These technologies allow businesses to track their inventory, manage orders, and monitor shipments in real-time.

One of the biggest advantages of logistics technology is that it improves efficiency. TMS and WMS software can help businesses optimize their supply chain, reduce transportation costs, and increase productivity.

For example, TMS software can be used to plan the most efficient routes for shipments, while WMS software can be used to automate warehouse operations such as inventory management and order fulfillment.

Logistics technology also improves visibility and transparency in the supply chain. Real-time tracking and monitoring of shipments enable businesses to keep their customers informed about the status of their orders. This not only increases customer satisfaction but also improves the reputation of the business.

Another advantage of logistics technology is that it enables businesses to make data-driven decisions. SCM software can provide businesses with valuable insights into their supply chain operations, such as demand forecasting and inventory management. This helps businesses make informed decisions about their operations, leading to improved efficiency and profitability.

The use of logistics technology has also led to the development of new delivery models, such as same-day delivery and last-mile delivery. These models have become increasingly popular with customers who value fast and reliable delivery.

The use of drones and autonomous vehicles for delivery is also becoming more common, further improving efficiency and reducing delivery times.

However, there are also challenges associated with logistics technology.

The initial cost of implementing these technologies can be high, and businesses may require additional training to use them effectively. Moreover, there are concerns about data security and privacy, as logistics technology relies on the use of data to optimize operations.

Logistics technology has revolutionized the way businesses handle their transportation and delivery operations. It has improved efficiency, transparency, and visibility in the supply chain, leading to increased customer satisfaction and profitability.

However, businesses need to be aware of the challenges associated with these technologies and take appropriate measures to address them.

You might also like

Read this article:

The Future of Logistics: How Technology is Revolutionizing the ... - Robotics and Automation News

May 4, 2023 TheNewswire - Vancouver, BC - Baru Gold Corp ("Baru" and its subsidiary PT. Tambang Mas Sangihe (TSXV:BARU) | (OTC: BARUF) ("TMS") or the "Company") is delighted to inform stakeholders and investors that the Company's work on Sangihe has received the National Vital Object designation. We are also announcing the withdrawal of the lawsuit filed by the Company, announced on August 25, 2022.

The Company holds a Contract of Work with the Government of Indonesia that provides the legal right to explore, construct, and produce gold on the Island of Sangihe. The Government of Indonesia must uphold the terms of the Contract. In August of 2022, the Company filed a lawsuit to resolve issues preventing the fulfillment of the Contract of Work's terms.

The objective of the court filing was to pursue financial damages or, preferably, appropriately support the Company and their contractual rights to mine gold on Sangihe Island. The lawsuit named the President of the Republic of Indonesia and national heads of government agencies, along with alleged illegal miners and their supporters in the Sangihe Police and local government.

The lawsuit praises President Joko and appeals for support in resolving documented issues created by his subordinates. Many of the individuals named in the lawsuit were operating for personal enrichment and actively interfering with or failing to support the Company. A key issue raised by the Company was local government officials and police refusing to protect Company staff and equipment while overtly supporting illegal mining. Without question, the refusal by the Sangihe Police to enforce the rule of law prevented the Company from entering production status.

The Company now believes the issues raised in the lawsuit are no longer present and has withdrawn the lawsuit.

The Company notes that President Joko explicitly acknowledged the harm of illegal mining and has ordered branches of the military and police to stop the practice. The Company is a supporter of President Joko. The Company also agrees with President Joko's comments on the environmental destruction, criminal activity, and economic harm from the loss of tax revenue caused by illegal mining across Indonesia. The Company is the largest taxpayer on Sangihe Island, the largest direct foreign investor, and is committed to environmental protection and community development on Sangihe Island.

The Company also notes significant leadership changes within the Regional North Sulawesi and Sangihe Police forces. The Regional North Sulawesi Police Force has entirely new leadership Police Chief (Kapolda) Setyo Budiyanto and Vice-Regional Head (Wakapolda) Jan Leonard de Fretes. Both men have prioritized removing all illegal mining operations in North Sulawesi, including Sangihe Island. Senior representatives of the Regional North Sulawesi Police Force have visited Sangihe Island to observe the illegal mining operations. They are fully aware of the false information maliciously spread about the Company.

The Company also wishes to welcome the new local head of Police on Sangihe (Kapolres) Dhana Ananda Syahputra. Since his appointment, the Company has noted the reorganization within the local Sangihe police force. The Company trusts that the local police will continue to enforce the rule of law and never allow illegal miners to flourish on Sangihe Island again.

National Vital Object

The Company is also happy to announce that the Sangihe Project has been designated a National Vital Object. The designation officially recognizes the Sangihe Project as vital to the national interests of Indonesia. With this designation, the Company is assigned a National Vital Object Maintainer. This individual is an official representative and will be the liaison with the Company. National Vital Object Maintainers role is to secure, protect and resolve any disruption or disorders directed at the National Vital Object. The State Police of the Republic of Indonesia is obligated to provide security assistance to a National Vital Object. As a National Vital Object, the Company receives special protections and priority treatment. Only a handful of entities are eligible for such a designation, including foreign embassies, national monuments, and projects vital to securing Indonesia's strategic sources of income.

Baru Gold CEO, Terry Filbert, commented, "I am thrilled with the recent developments. Receiving the National Vital Objects designation, the support of the Indonesian government, police, and the restoration of the rule of law, changes literally everything. To be very clear, we have strong local support from the community on Sangihe. We have worked hard to develop relationships with residents and will continue to do so. Once in operation, the economic and development opportunities we will provide will beneficially impact everyone on Sangihe not just concentrate wealth into the hands of a few. For the last two years, the Sangihe community has literally been terrorized by illegal miners and their vocal supporters who have opposed our operations. We will never get the people benefiting from the illegal mining supporting a legal mining company but our National Vital Object designation now obligates the State Police to protect our work on Sangihe."

The Company also wishes to stress that while it has withdrawn the lawsuit, it will continue to pursue the illegal miners and their supporters in both criminal and civil courts. The Company has already filed criminal and civil complaints against individuals that have broken the laws of Indonesia and harmed the Sangihe community.

In Indonesia, the penalty for illegal mining is up to 5 years of prison and approximately CAD $9 Million in fines.

ABOUT SANGIHE GOLD PROJECT

The Sangihe Gold Project (Sangihe) is located on the Indonesian island of Sangihe, off the northern coast of Sulawesi. Sangihe has an existing National Instrument 43-101 inferred mineral resource of 114,700 indicated and 105,000 inferred ounces of gold, as reported in the Company's Independent Technical Report on the Mineral Resource Estimates of the Binebase and Bawone Deposits, Sangihe Project, North Sulawesi, Indonesia (May 30, 2017). Readers are cautioned that mineral resources that are not mineral reserves do not have demonstrated economic viability.

The Company intends to proceed to production without the benefit of first establishing mineral reserves supported by a feasibility study. The Company cautions readers that the any production decision made by the Company will not be based on a NI 43-101 feasibility study of mineral reserves that demonstrates economic and technical viability and as such, there may be involved increased uncertainty and various technological and economic risks.

The Company's 70-percent interest in the Sangihe-mineral-tenement Contract of Work (CoW) is held through PT. Tambang Mas Sangihe (TMS). The remaining 30-percent interest in TMS is held by three Indonesian corporations. The term of the Sangihe CoW agreement is 30 years upon commencement of the production phase of the project.

Baru has met all the requirements of the Indonesian government and has been granted its environmental permit.

ABOUT BARU GOLD CORP.

Baru Gold Corporation is a dynamic junior gold developer with NI 43-101 gold resources in Indonesia, one of the top ten gold producing countries in the world. Based in Indonesia and North America, Barus team boasts extensive experience in starting and operating small-scale gold assets.

BARU GOLD CORP

Per: Terry Filbert

Terry Filbert, Director

President & CEOThis email address is being protected from spambots. You need JavaScript enabled to view it. +1-206-890-8285

For investor contacts more information, please contact:

Kevin Shum

Investor Relations

This email address is being protected from spambots. You need JavaScript enabled to view it. 647-725-3888 ext 702

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this News Release, which are not historical in nature, constitute forward looking statements within the meaning of that phrase under applicable Canadian securities law. These statements include, but are not limited to, statements or information concerning future work programs, results and timing of any work programs, the Companys performance or events as of the date hereof. These statements reflect managements current assumptions and expectations and by their nature are subject to certain underlying assumptions, known and unknown risks and uncertainties and other factors which may cause actual results, performance or events to be materially different from those expressed or implied by such forward looking statements. Those risks include the interpretation of drill results; the geology, grade and continuity of mineral deposits; the possibility that future exploration, development or mining results will not be consistent with our expectations; commodity and currency price fluctuation; failure to obtain adequate financing; regulatory, recovery rates, refinery costs, and other relevant conversion factors, permitting and licensing risks; general

Read the rest here:

Baru Gold Designated "National Vital Object" and Updates ... - Junior Mining Network

President,Adani Ports & Special Economic Zone

Completing 4 Decades of experience, Capt. Sandeep Mehta is one of the foremost stalwarts of the Indian Maritime industry. During this tenure, Capt Mehta has acquired considerable expertise in the various aspects of the Port Management, Shipping, Logistics and Infrastructure business.

Capt Mehtas areas of responsibility have encompassed Supply Chain and International Logistics, Bulk & Container port operations, Global Liner Shipping, Port Infrastructure development and Management.

Embarking upon his career as a seafarer, Capt Mehta rapidly progressed up the ranks to become a Captain, assuming command of ships which were then amongst the largest in the merchant carrier fleet. After 12 years of sailing, Capt Mehta decided to move offshore, where he handled a number of successively senior positions in the Container Shipping industry.

After successful completion of a challenging stint in the highly competitive Container Shipping industry, Capt. Mehta ventured into the then nascent private port industry in India, joining the Adani Group as President and CEO of Mundra Ports and SEZ. During this period, Mundra rapidly evolved from a minor port to grow into Indias largest private port, in various businesses including Container Terminals, Bulk, Liquid and Automobile Logistics.

He was also responsible for development of Container Terminals, Private Rail Operations, Container Freight Stations & Inland Container Depots and grain storage facilities for the Adani Group in India.

He later took up the position of CEO for Adani ports in Australia, where he was a part of core management team, tasked to execute Adani Groups integrated mine, rail and port development projects, including new port expansions.

Capt. Mehta currently serves as the President for Business Development activities of Adani Ports and its overseas port projects.Capt. Mehta has over the years augmented his practical knowledge by undergoing various specialised courses in the field of Shipping and Transport.

Capt. Mehta has been a member of the Institute of Chartered Ship Brokers, London and also the Company of Master Mariners, as well as being a Loss Assessor & Surveyor.

During his spare time, Capt. Mehta writes about issues related to the Maritime and Supply Chain industries. He is also a regular speaker at various Business and Industry forums and has been invited as a guest lecturer by various Management institutes. Capt. Mehta is also passionate about mentoring young people and helping them develop their skills. He firmly believes that a Skilled India will lead to a Developed India.

See the rest here:

Early Bird offer for TMS Awards - The Maritime Standard

When members of the Living Well Women group learned that St Helen's Private Hospital in Hobart was closing next month, many cried.

"It's devastated all of us, many of us were in tears, we're in shock, disbelief, at the fact that we're having our safety net, our hospital taken away from us," said group member Pip Swan.

"We've been running that group for 15 years now, in that same room, and to think that's going to shut down is damaging all of us."

"For some women in this group, the only thing they get to do is go to that group. They don't leave their houses otherwise, and they've just lost their safety net altogether."

The St Helen's hospital has 31 general psychiatric inpatientbeds and an eight-bed mother-baby unit, which is currently the only residential treatment facility for mothers struggling with mental health problems and babies with sleeping problems.

OwnerHealthscopecan notafford the repairs and upgrades the hospital needs to keep operating, saying the ageing facility and declining demand meant a multi-million-dollar investment was not viable.

Healthscope toldpatients, staff, and consulting doctors on Tuesday that the hospital would close in late June.

Ms Swan said many of the women in her group accessed treatments at the hospital including electro-convulsive therapy (ECT) andtranscranial magnetic stimulation (TMS), which are the only approved effective therapies for treatment-resistant depression.

"So many more people need to come in and use this service, and taking it away is going to have such a detrimental effect on a massive group of people in Hobart and Tasmania," Ms Swan said.

"There's no other private mental health facility like this [in Tasmania]."

Psychiatrist Marzena Rybak was running the Living Well Women group on Tuesday and had to break the news of the closure to her patients.

She has operated out of consulting rooms at the hospital for about 20 years and has more than 2,000 patients.

She isunsure how she will be able to help patients who need in-patient treatment when she can no longer admit them to the St Helen's Private Hospital.

"When they're in crisis, when they require inpatient care, we have no place to put them in," Dr Rybak said.

Tasmania's only other private inpatient mental health beds are at the Hobart Clinic, in Rokeby, but Dr Rybak said it was a small facility that was usually at capacity.

Dr Rybak is also worried for her patients who need regular ECT and TMS sessions to manage their treatment-resistant depression.

"If we don't have that, those people's lives will be ruined. I don't know what I'm going to do with them," she said.

"As a doctor that's my primary concern, and I don't have answers."

The St Helen's Private Hospital has five TMS machines, the Hobart clinic has oneand there is one at a private clinic in Bellerive.However, that service is only available to patients who have not had TMS treatment before, due to Medicare rules.

TMS is not available in the public system run by the Tasmanian Health Service.

ECT is also available at the Hobart Clinic and the Royal Hobart Hospital, but Dr Rybak said there werewaiting lists for those.

Healthscope said there hadbeen a 15 per cent decline in demand for in-patient services at the hospital, with about 24 of its 39 beds usually occupied.

It said in 2022, 134 patients attended day programs at the hospital, 28 patients received ECT and there were 122 TMS patients.

Dr Rybak disagreedthat demand for mental health treatment services wasfalling.

"We are at breaking point right now and imagine cutting down 39 beds, plus all the outpatient services plus ECT plus TMS, it would be a total disaster for the whole state," Dr Rybak said.

Healthscope said it would work with doctors and other health providers to transition its outpatient services to other providers and facilities.

The Tasmanian Health Service has already stepped in with plans to open its own mother-baby unit before the St Helen's Private Hospital closes.

"The THS is also working with other non-government providers to ensure the health system is ready to meet any additional patient demand for in-hospital services," Premier and Health Minister Jeremy Rockliff said on Tuesday.

"I would particularly like to recognise The Hobart Clinic for their early engagement in this planning process and theircommitment to future service expansion."

Set the ABC News website or the app to "TasmaniaTop Stories"from either the homepage or the settings menu in the appto continue getting the same national news but with a sprinkle of more relevant state stories.

Here's a taste of the latest stories from Tasmania

Link:

St Helen's Hospital patient says many are 'devastated' by its imminent closure - ABC News

TMS therapy is a short outpatient procedure that uses short pulses of magnetic fields to stimulate nerve cells within the area of the brain thought to control mood. TMS therapy is performed at Sibley under supervision while the patient remains awake and alert.

The treating clinician positions a treatment coil over the left prefrontal cortex, the part of the brain involved with mood regulation. Through the treatment coil, the TMS therapy system generates highly concentrated magnetic fields that turn on and off rapidly. These magnetic fields are the same type and strength as those produced by a magnetic resonance imaging (MRI) machine. When these pulses are administered in rapid succession, they can produce longer-lasting changes in brain activity.

TMS has been shown to be a safe and well-tolerated procedure that can be an effective treatment for patients with depression who have not benefited from antidepressant medications or cannot tolerate antidepressant medications due to side effects. As of September 2014, Sibley has begun providing treatment via a new type of TMS technology, called deep TMS, or dTMS. This system has recently been approved by the FDA for clinical use with patients and requires shorter and less frequent treatment sessions than earlier forms of TMS. dTMS sessions last 20 minutes and are given daily over four to five weeks.

dTMS therapy is not appropriate for all patients. Before scheduling you for treatment, you must first be evaluated by one of our TMS psychiatrists to determine if dTMS would be safe and appropriate for you.

To be evaluated for outpatient dTMS treatment or to learn more please contact Agnes Bradley-Wright, by email at abradle8@jhmi.eduor call 202-660-6702.

More information about dTMS is available online at http://www.brainsway.com/us.

Depression is a serious medical illness affecting more than 14 million American adults every year, which is typically treated with antidepressant medications.

Although antidepressants can be effective for many patients, some people do not receive adequate benefit from antidepressants and/or cannot tolerate their side effects. For these patients, TMS therapy offers an alternate treatment method for depression.

Read the original:

Transcranial Magnetic Stimulation (TMS) | Sibley Memorial Hospital in ...

Psychiatric services at Sibley are provided by the hospitals Behavioral Health Unit.In surveys conducted by the Washingtonian magazine, Sibleys inpatient unit has consistently been among the top choices for psychiatric treatment in the Washington, D.C. region.

Sibley Memorial Hospitals inpatient Behavioral Health Program provides acute, short-term treatment for patients ages 18 and older in need of a safe, secure and therapeutic environment. The clinical treatment program is designed to return patients to their optimal levels of functioning as quickly as possible.

The inpatient program includes:

Sibley is one of very few providers in the area who offers the next generation of transcranial magnetic stimulation (TMS) therapy, known as deep TMS or dTMS. This therapy, given on an outpatient basis, is a powerful depression treatment for patients for whom medications are inappropriate or ineffective.

Sibley also offers electroconvulsive therapy (ECT) for outpatients when clinically indicated.

For more information about the psychiatry program, please contact social work at 202-660-7445.

To be evaluated for outpatient dTMS treatment or to learn more, please contact Agnes Bradley-Wright, TMS coordinator, at abradle8@jhmi.edu or 202-660-6702.

If you have questions about inpatient or outpatient ECT services, please contact Ivy Hunt, ECT coordinator, at ihunt4@jhmi.edu or202-243-5178.

Patients are evaluated at the Sibley Memorial Hospital Emergency Department for medical clearance before being admitted into the unit. Admissions for inpatient services are accepted 24 hours a day.

Physicians, psychologists, social workers and other mental health professionals may refer a patient. The final decision regarding admission is made by an attending Sibley Hospital psychiatrist. To make a referral, medical professionals may call 202-537-4770, or a patient can present themselves to the Emergency Department for an evaluation.

The Behavioral Health Unit is a voluntary unit; therefore all patients must sign a voluntary consent form to be treated. The program does not take involuntary or court committed patients.

Generally, most patients are treated for a period of seven to 10 days. The length of stay is highly individualized and dependent on a number of factors, including medical needs, placement issues and follow-up care. The goal of the Behavioral Health Unit is to provide all patients with an individualized treatment plan that best suits their particular needs and diagnosis.

Please contact your individual insurance provider to inquire if treatment is covered. Many insurance plans are accepted by the hospital. Private insurance companies often cover part or most of the cost of care, as do Medicare and Medicaid.

Monday through Friday, 3:30 p.m. to 4:30 p.m. and 6:30 p.m. to 8p.m.; weekends, 2:30 p.m. to 4:30 p.m. and 6:30 p.m. to 8p.m. Exceptions to this schedule may be granted through the patients physician.

Depression is a serious medical illness affecting more than 14 million American adults every year, which is typically treated with antidepressant medications. Although antidepressants can be effective for many patients, some people do not receive adequate benefit from antidepressants and/or cannot tolerate their side effects. For these patients, TMS therapy offers an alternate treatment method for depression, first approved by the U.S. Food and Drug Administration in 2008.

TMS has been clinically proven for the treatment of major depression in adults who have failed to achieve satisfactory improvement from prior antidepressant medication.

At Sibley, we have recently switched to a next-generation TMS system, known as deep TMS (or dTMS), which provides TMS treatment in half the time of the previous system.

TMS therapy is a short outpatient procedure that uses short pulses of magnetic fields to stimulate nerve cells within the area of the brain thought to control mood. TMS therapy is performed at Sibley under supervision while the patient remains awake and alert.

The treating clinician positions a treatment coil over the left prefrontal cortex, the part of the brain involved with mood regulation. Through the treatment coil, the TMS therapy system generates highly concentrated magnetic fields that turn on and off rapidly. These magnetic fields are the same type and strength as those produced by a magnetic resonance imaging (MRI) machine. When these pulses are administered in rapid succession, they can produce longer-lasting changes in brain activity.

As of September 2014, Sibley has begun providing treatment via a new type of TMS technology, called deep TMS, or dTMS. This system has recently been approved by the FDA for clinical use with patients and requires shorter and less frequent treatment sessions than earlier forms of TMS. dTMS sessions last 20 minutes and are given daily over four to five weeks.

To be evaluated for outpatient dTMS treatment or to learn more please contact Agnes Bradley-Wright, by email atabradle8@jhmi.eduor call 202-660-6702.

TMS has been shown to be a safe and well-tolerated procedure that can be an effective treatment for patients with depression who have not benefited from antidepressant medications or cannot tolerate antidepressant medications due to side effects.

dTMS therapy is not appropriate for all patients. Before scheduling you for treatment, you must first be evaluated by one of our TMS psychiatrists to determine if dTMS would be safe and appropriate for you.

See the original post:

Psychiatry | Sibley Memorial Hospital in Washington, D.C.

Want To Win Big? Experts Suggest To Choose TMS Network (TMSN) Over Arbitrum (ARB) And Polygon (MATIC) |  Bitcoinist

Read the original here:

Want To Win Big? Experts Suggest To Choose TMS Network (TMSN) Over Arbitrum (ARB) And Polygon (MATIC) | - Bitcoinist

TMS Network (TMSN) AI Infrastructure Will Give You 100x Returns, Way Better Than SingularityNET (AGIX) And  Bitcoinist

Read this article:

TMS Network (TMSN) AI Infrastructure Will Give You 100x Returns, Way Better Than SingularityNET (AGIX) And - Bitcoinist

TMS aka rTMS for repetitive transcranial magnetic stimulation is a noninvasive type of brain stimulation treatment. Its used for treating depression, migraine, and OCD, among other conditions.

During TMS, magnetic pulses repeatedly stimulate nerve cells in your brain. The pulses are aimed at specific areas of your brain thought to be involved in mood (typically the frontal cortex).

While the way it works and how it can help people with depression (and other conditions) isnt completely understood, essentially, the pulses excite or inhibit certain neurons. In turn, some people find relief from their depression symptoms.

TMS is usually prescribed to people who havent found success with other treatments, such as antidepressants for depression.

Some people get it confused with ECT (electroconvulsive therapy) and other brain stimulation therapies, but theyre not the same. Unlike ECT, you dont need to be sedated, and it doesnt involve seizures. And in TMS, nothing is implanted or surgical.

So TMS is one of the most noninvasive of all brain stimulation therapies.

I have treatment-resistant depression, so finding treatments that work (and keep working) has not been an easy road. On my good days, I try to look at it as a process that will continue to evolve. And who knows what new scientific discoveries will bring?

So when TMS was presented to me as an option, I said yes without really knowing what it would be like.

The first step before TMS treatment can begin is getting it prescribed.

For me, I already had a psychiatrist, so I didnt have to go through the process of finding a new doctor or establishing a relationship you might need to meet with a doctor a few times before they know enough about you and your treatment history to prescribe TMS.

My psychiatrist knew my full medication history and was the one who first brought up the option. When I agreed, it was time for the approval process.

The approval process will vary based on many factors, such as accessibility in your area, your insurance, and the availability of the clinics.

You may also want to reach out to your insurance to find out what they cover. Mine covered the cost and just involved a copay, but the cost of TMS may be steep for others one study mentions between $6,000 to $12,000.

Your insurance might also have different requirements before approving TMS. Mine defines treatment-resistant as having tried at least two antidepressants, but other insurances vary, so you might need to prove youve taken more medications than that.

My doctor completed the paperwork, so that was one burden off my shoulders. Then I waited for the clinic to contact me.

I had to wait about a month and a half from the time my psychiatrist filled out the paperwork until the time I walked through the door for my first appointment.

The first appointment when starting TMS is different from other appointments, not just because you have to fill out the offices paperwork. The first session sets you up for the rest of your sessions and takes about an hour.

In the intake appointment, they figure out where the device needs to be positioned, so its targeting the ideal part of your brain, as well as the power level (or motor threshold).

The technician started by taking measurements of my head to make sure the device (TMS coil, specifically) was properly positioned.

When I first started TMS, the machine they were using was huge, and the coil was in a giant helmet. By the end of my treatments, theyd gotten a new machine where the coil looked more like a shower head and was far less claustrophobic.

The technician adjusted (and adjusted again) as they figured out exactly where to position the coil. But for me, it was just a lot of staring at a wall while wearing earplugs.

Then they tested my motor threshold. The motor threshold is the minimum amount of power needed its sort of like figuring out the dose.

I cant think of a better way to describe TMS than it feeling like youre being vigorously tapped on the head over and over again.

When they tested my motor threshold, they found it by seeing how much power it took to make my thumb twitch. It felt like someone was gradually tapping more forcefully until the desired twitch was achieved.

Honestly, the first appointment was strange. It felt like Id never get used to the sensations (I did), and it was kind of frustrating just sitting there while they made the tiniest of adjustments.

And while I never had side effects in the future, I did get dizzy after that first appointment and had to sit and sip water until the tunnel vision went away. Dizziness is a known side effect.

After that first appointment, it started feeling more like a routine. There was less adjustment, less time involved, and I never felt lightheaded again (just one or two headaches).

But appointments were definitely an investment of time you need to have treatment 5 days a week for the first 4 to 6 weeks. The sessions were only 20 minutes, but if my job hadnt been flexible, I wouldnt have been able to manage.

Every weekday for 4 weeks, Id come in, take my glasses off, put in my earplugs, and sit with my eyes closed for 20 minutes. The technician usually gave me a blanket if I forgot a jacket since the fans blowing from the machine blow right on you and make the room cold.

I started trying to meditate since sitting with my own thoughts for 20 minutes could turn into a negative thought spiral that Id recommend to no one.

Once a week, Id fill out a questionnaire to monitor my symptoms before, during, and at the end of treatment.

After the 4 weeks were up, I continued treatment. But I went from 5 days a week to 3, then 2, then 1, before stopping.

See the article here:

TMS: What It Felt Like for Me I Psych Central